Screener
Boston Scientific BSX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Boston Scientific’s 8-K, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 6:33 AM EDT
- Accession
- 0000885725-26-000051
FAQ
- What is Boston Scientific's EPS (diluted)?
- Boston Scientific (BSX) reported EPS (diluted) of $0.61 in Q2 2026.
- How has Boston Scientific's EPS (diluted) changed year-over-year?
- Boston Scientific's EPS (diluted) increased by 15.1% year-over-year, from $0.53 to $0.61.
- What is the long-term trend for Boston Scientific's EPS (diluted)?
- Over 4 years (2021 to 2025), Boston Scientific's EPS (diluted) has grown at a 29.5% compound annual growth rate (CAGR), from $0.69 to $1.94.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Boston Scientific's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude